Medical Cyclotron Market Analysis 2026

CURRENT SCENARIO OF THE MEDICAL CYCLOTRON MARKET

Key factors driving the growth of the Medical Cyclotron Market

• The high prevalence of cancer is one of the factors driving the market for Medical Cyclotron

For instance, according to the Global Cancer Observatory data, over 19 million people across the globe suffered from cancer in 2020. The report also estimated that the risk of developing cancer before the age of 75 years was around 20.4%.
(Source; https://pubmed.ncbi.nlm.nih.gov/33538338/)

According to the publication by the ASCO Post in June 2021, every year, there are around 50,000 new cases of cancer in Morocco, causing around 13.4% of deaths in the country. According to the same source, the most common type of tumor, regardless of gender, is breast cancer which accounts for 20% of cases while lung cancer (11.4%) is in the second place, followed by colon cancer (6.7%).
(Source; https://ascopost.com/issues/june-25-2021/cancer-in-morocco-access-to-innovative-treatments-and-research-status/)

According to an article published by the National Centers for Biotechnology Information in July 2020, there is an increasing prevalence of ischemic heart disease across the globe, as it affects 1,655 per 100,000 individuals, which may rise up to 1,845 per 100,000 individuals by 2030.
(Source; https://pubmed.ncbi.nlm.nih.gov/32742886/)

SPECT and PET are modern systems used to detect and treat cancer, cardiovascular diseases, and other neurology related diseases. PET installations across the world have cyclotrons beside a PET machine. PET radioisotopes have relatively short half-lives. Once the radioactive isotope is produced, it has to be synthesized and injected into a patient as soon as possible. 

According to the American Nuclear Society, 90% of radioisotopes are used in gamma cameras or PET scan nuclear diagnostics. Remaining 10% are used in radioactive therapeutics drugs to treat diseases such as cancer, heart diseases, gastrointestinal, endocrine, and neurological disorders. 
(Source; https://world-nuclear.org/information-library/non-power-nuclear-applications/radioisotopes-research/radioisotopes-in-medicine.aspx)

Molecular imaging with novel radiopharmaceuticals has been engineered to target specific subcellular processes and improve diagnostic accuracy using radioactive molecule as a tracer. These factors are expected to bolster the global medical cyclotron market in the next few years.

• Rise in awareness about efficient utilization of radiopharmaceuticals  stimulating growth for the market

With less harmful side effects, radionuclide therapy has become an effective treatment option for chronic illnesses. Consequently, there has been a significant increase in the manufacture of radioisotopes worldwide for use in nuclear medicine and medical imaging. 

The World Nuclear Association reports that radioisotopes find applications in medical practices across more than 10,000 hospitals worldwide. Around 90% of medical procedures, including diagnosis and treatment of conditions such as infectious diseases, cancer, and neurological disorders, rely on these radioisotopes. 
(Source;https://world-nuclear.org/information-library/non-power-nuclear-applications/radioisotopes-research/radioisotopes-in-medicine.aspx#:~:text=In%20some%20cases%20radiation%20can,the%20procedures%20are%20for%20diagnosis.)

Medical technology has advanced due to a constant rise in research and development efforts and an expansion in the patient pool suffering from diseases like cancer. As a result, cutting-edge, creative solutions with the goal of enhancing treatment outcomes have been introduced. As such, the medical cyclotron market is expected to experience substantial expansion in the coming years on a global scale.

Key factors hampering the Market growth

• The high cost and complex logistics of medical cyclotrons is one of the factors limiting the market growth. likely to restrain market expansion

One of the things impeding the growth of the medical cyclotron market is its high cost and intricate logistics. Experts typically favour unshielded cyclotrons since self-shielding slows down cyclotron upkeep and repair. The installation of an unshielded cyclotron requires a certain type of concrete vault. 

The vault often takes up more room than a self-shielded device. Despite the relatively low cost of concrete, the total cost of cyclotron unit setup is more than that of the vault. Thus, during the course of the forecast period, the high cost and intricate logistics related to medical cyclotrons are anticipated to constrain the global market's expansion.

Strict regulatory requirements for cyclotron installation and a lack of technical competence are likely to act as market hurdles for the medical cyclotron market expansion within the previously stated projected timeframe.

Opportunity

• Medical cyclotron technology in nuclear medicine is one of the key market trends fueling the market growth. 

Globally, medical cyclotrons and nuclear medicine are essential to the management of disease. Furthermore, for more than thirty years, radiopharmaceuticals have been widely utilised in medicine for diagnostic imaging and, in certain situations, as therapy. 

Accurate disease diagnosis is made easier for doctors by the use of nuclear medicine. Since radioisotopes are essential to the production of radiopharmaceuticals, the growing application of nuclear radioisotopes in nuclear medicine has a beneficial impact on the market's expansion and demand for medical cyclotrons. 

The growing prevalence of cancer patients has led to a global surge in demand for nuclear scans. Furthermore, medical cyclotrons are being used by hospitals and diagnostic centers more frequently in the areas of cardiology, neurology, and oncology. Furthermore, the leading competitors are introducing technologically advanced diagnostic tools, which is expected to boost their overall market share and positively affect the demand for medical cyclotrons worldwide.
In industrialized countries, 10% of patients receive treatment using radioisotopes, and one in fifty patients is thought to use nuclear medicine for diagnosis each year. One of the most cutting-edge techniques for identifying and treating malignant cells is radiotherapy. 

According to the World Nuclear Association, about 40 million procedures are carried out each year globally with nuclear medicines, with an annual growth rate of 5.0% per annum. 
(Source;https://world-nuclear.org/information-library/non-power-nuclear-applications/radioisotopes-research/radioisotopes-in-medicine.aspx)

How did COVID–19 Impact the Medical Cyclotron Market?

The entire market share and demand for medical cyclotrons were positively impacted by COVID-19. With the use of medical cyclotron technology, the frequency of the novel coronavirus (COVID-19) is being estimated to range from 30 kHz to 500 kHz. Businesses in the medical cyclotron industry are engaged in research projects to try and develop antiviral drugs that should lessen the harmful effects of the virus. 

Businesses are placing greater emphasis on genome sequencing to create COVID-19 medicines in an effort to increase sales of medical cyclotrons. Medical cyclotron firms are using low-frequency magnetic fields (LFMF) in transdisciplinary research to find treatments for the deadly virus. This aspect is expected to cause the need for medical cyclotrons to increase dramatically between 2022 and 2032. 

A significant rate of illness and mortality has been associated with the COVID-19 outbreak. As a result, R&D efforts in healthcare organisations have increased. A crucial component of the research is the use of medical cyclotron technology as researchers create vaccinations and antiviral drugs to fight the uncommon virus. 

Due to the high demand for antiviral drugs and medical cyclotrons, the use of these instruments to measure the prevalence of COVID-19 infections has expanded. On the other hand, medical cyclotrons are associated with substantial radiation generation, which may pose a health risk to researchers and scientists. Over the course of the projected period, this aspect is probably going to hurt sales of medical cyclotrons. 

Our study will explain complete manufacturing process along with major raw materials required to manufacture end-product. This report helps to make effective decisions determining product position and will assist you to understand opportunities and threats around the globe.

The Global Medical Cyclotron Market is witnessing significant growth in the near future.

In 2023, the Conventional Cyclotrons segment accounted for noticeable share of global Medical Cyclotron Market and is projected to experience significant growth in the near future.

The Low-energy (<20 MeV) segment is expected to expand at the significant CAGR retaining position throughout the forecast period.

Some of the key companies Ion Beam Applications S.A. , Siemens Healthineers and others are focusing on its strategy building model to strengthen its product portfolio and expand its business in the global market.

Frequently Asked Questions (FAQs)